Serum levels of LDH, CEA, and CA19-9 are prognostic factors that assist in the diagnosis and survival prediction of patients with BM from GC (Kobayashi et al., 2005; Turkoz et al., 2014; Mikami et al., 2017). This evidence concerns the gene CEACAM5 and gastric cancer.